Obesity and melanoma: a new link
Obesity and melanoma: a new link Melanoma p16INK4A Obesity CDKN2A Adipocytes beta-catenin extracellular vesicle Laurence Niéto – MELASPHINX Team – Métabolisme du céramide dans le mélanome : des mécanismes moléculaires à l’immunothérapie Obesity is a...A new immunotherapy strategy for melanoma patients.
A new immunotherapy strategy for melanoma patients. Anti-TNF Anti-PD-1 Anti-CTLA-4 melanoma Clinical trial Bruno Ségui a Nicolas Meyer – Equipe “MELASPHINX : Sphingolipid metabolism: From basic mechanisms to immunotherapy Melanoma is a skin cancer with a poor...
Reprogramming a family of lipids to increase the effectiveness of melanoma immunotherapy.
Reprogramming a family of lipids to increase the effectiveness of melanoma immunotherapy. ceramide metabolism Anti PD-1 anti-CTLA-4 melanoma immunotherapy melanoma resistance Bruno Ségui & Céline Colacios CRCT team : Ceramide metabolism in melanoma Immunotherapy...
More news
Very soon more news from this team to follow….
